Funded Project Details - FY2021
|Title:|| Claudin-3, Gut Dysbiosis and Inflammatory Bowel Disease|
Amar B Singh
|Congressional District Code:
||Biomedical Laboratory R&D
|| April 2020 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Inflammatory bowel disease (IBD), consisting primarily of the ulcerative colitis (UC) and Crohn’s disease (CD), is a group of debilitating auto-immune disorders, which significantly affect one’s life-style and carry a high risk of colon cancer. While significant advances have been made in the clinical management of these diseases, the overall incidence rate and disease severity in active duty army personnel and veterans is constantly increasing possibly due to the high level of stress involved....
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.